UNSPSC 51263406: Tamsulosin hydrochloride

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C20H28N2O5S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 11SV1951MR, chemically known as benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-, monohydrochloride, (r)- but more generally known as tamsulosin hydrochloride, which bears US NIH Compound Identifier 5362376.

UNSPSC 51263406 Tamsulosin hydrochloride is a Commodity code nominally designating a specific pharmaceutical product, but recent state and local procurement activity tagged under this code does not reflect actual solicitation for tamsulosin or related alpha-blocker medications. The two recent opportunities in the record — a Seminole County, Florida IFB for naloxone and drug deactivation systems, and a Texas Health and Human Services Commission RFI regarding direct-to-manufacturer prescription programs — represent pharmaceutical procurement and pharmacy benefit management strategy respectively, neither of which aligns with the code's nominal scope. State and local governments using UNSPSC taxonomy occasionally misapply Commodity codes when categorizing opportunities; this code appears to be one instance where the tagging does not match the actual work being purchased.

The geographic activity visible in the record spans Florida and Texas, with Seminole County representing county-level health purchasing and the Texas HHS Commission representing state-level pharmacy policy procurement. The Seminole County solicitation (IFB 60459723LAS, due July 26, 2023) sought quarterly deliveries of naloxone and safe drug deactivation systems through competitive bidding with a two-year initial term and optional one-year renewal. The Texas RFI (HHS0017013, posted April 3, 2026) gathered vendor capabilities for implementing direct manufacturer prescription fulfillment outside traditional pharmacy benefit manager channels. No active opportunities targeting tamsulosin or similar pharmaceuticals appear in current state and local records under this code, suggesting either limited recent procurement activity for this specific product line or continued misclassification of pharmaceutical opportunities across the taxonomy.